The Brazilian Journal of Infectious Diseases · 2012 · 33 citations · 34 references
CA-MRSA must be considered when treating skin and soft tissue infections, especially in developing countries. Empirical use of agents active against CA-MRSA is warranted for patients presenting with serious SSTIs.
34